Literature DB >> 1682392

Expression of intercellular adhesion molecule-1 (ICAM-1) in the skin of patients with systemic scleroderma.

S Majewski1, N Hunzelmann, J P Johnson, C Jung, C Mauch, H W Ziegler-Heitbrock, G Riethmüller, T Krieg.   

Abstract

The expression and tissue distribution of intercellular adhesion molecule-1 (ICAM-1) in skin biopsies from 12 patients with systemic (SSc) and localized (LS) scleroderma was studied and compared to the biopsies from patients with lupus erythematosus (LE) and normal individuals. In normal human skin ICAM-1 expression was restricted to the vascular endothelium, infiltrating mononuclear cells (MNC), and to few individual keratinocytes. In the inflammatory stage of SSc, however, the expression of ICAM-1 was dramatically increased at the site of MNC infiltrates and could also be detected on fibroblast-like cells lying well apart from these infiltrates in the deep dermis. In contrast, in LS ICAM-1 was expressed mainly at the sites of MNC infiltrates. In LE ICAM-1 expression was confined to the keratinocytes, endothelial cells, and mononuclear cells in the upper parts of the dermis. Analysis of serial tissue sections from patients with SSc demonstrated also colocalization of staining of ICAM-1 around blood vessels with LFA-1-positive lymphocytes. Increased expression of ICAM-1 in the dermis of patients with SSc may represent an important mechanism by which MNC become localized and retained at a site of connective tissue inflammation, leading to the activation of fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682392     DOI: 10.1111/1523-1747.ep12483739

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  15 in total

Review 1.  Integrin signaling in fibrosis and scleroderma.

Authors:  H A Gardner
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

Review 2.  T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

Authors:  C Chizzolini
Journal:  Springer Semin Immunopathol       Date:  1999

3.  Dermatan sulfate activates nuclear factor-kappab and induces endothelial and circulating intercellular adhesion molecule-1.

Authors:  S F Penc; B Pomahac; E Eriksson; M Detmar; R L Gallo
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

4.  Systemic sclerosis stimulates angiogenesis in the chick embryo chorioallantoic membrane.

Authors:  D Ribatti; F P Cantatore; A Vacca; M D'Amore; R Ria; L Roncali; V Pipitone
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

5.  Increased transendothelial migration of scleroderma lymphocytes.

Authors:  G H Stummvoll; M Aringer; J Grisar; C W Steiner; J S Smolen; R Knobler; W B Graninger
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

6.  Expression of ectopeptidases in scleroderma.

Authors:  G Bou-Gharios; J Osman; A Atherton; P Monoghan; R Vancheeswaran; C Black; I Olsen
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

7.  Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity.

Authors:  U Fiocco; M Rosada; L Cozzi; C Ortolani; G De Silvestro; A Ruffatti; E Cozzi; C Gallo; S Todesco
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

8.  Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.

Authors:  Masahide Kubo; Joanna Czuwara-Ladykowska; Omar Moussa; Margaret Markiewicz; Edwin Smith; Richard M Silver; Stefania Jablonska; Maria Blaszczyk; Dennis K Watson; Maria Trojanowska
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

9.  Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis.

Authors:  Y Kawaguchi; K Suzuki; M Hara; T Hidaka; T Ishizuka; M Kawagoe; H Nakamura
Journal:  Ann Rheum Dis       Date:  1994-08       Impact factor: 19.103

10.  Altered adhesion molecules expression on peripheral blood mononuclear cells from patients with systemic sclerosis and clinical correlations.

Authors:  Heloisa Helena Braga Sawaya; Romy Beatriz Christmann de Souza; Solange Carrasco; Claudia Goldenstein-Schainberg
Journal:  Clin Rheumatol       Date:  2009-02-19       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.